amoxicillin/clavulanic acid centrient
centrient pharmaceuticals netherlands b.v. - amoksicilinas/klavulano rūgštis - milteliai geriamajai suspensijai - 200 mg/28,5 mg/5 ml - amoxicillin and beta-lactamase inhibitor
zoledronic acid medac
medac gesellschaft für klinische spezialpräparate mbh - zoledrono rūgšties monohidratas - fractures, bone; cancer - narkotikai kaulų ligų gydymui - skeleto pažeidimų susijusių reiškinių (patologinių lūžių, stuburo spaudimo, radiacija ar chirurginis arba naviko sukeltai hiperkalcemijai) suaugusiems pacientams su kaulus piktybinis procesas. gydymo suaugusių pacientų su naviko sukelta hypercalcaemia (tih).
zoledronic acid zentiva
zentiva k.s. - zoledrono rūgštis - koncentratas infuziniam tirpalui - 4 mg/5 ml - zoledronic acid
ibandronic acid mylan
lex ano, uab - ibandrono rūgštis - plėvele dengtos tabletės - 150 mg - ibandronic acid
alendronic acid actiopharma
actiofarma, uab - alendrono rūgštis - tabletės - 70 mg - alendronic acid
ibandronic acid actavis
actavis group ptc ehf. - ibandrono rūgštis - plėvele dengtos tabletės - 150 mg - ibandronic acid
zoledronic acid hikma [ribometa]
edupharma, uab - zoledrono rūgštis - koncentratas infuziniam tirpalui - 4 mg/5 ml - zoledronic acid
edistride
astrazeneca ab - dapagliflozino propanedilo monohidratas - diabetes mellitus, type 2; heart failure, systolic; heart failure; renal insufficiency, chronic - narkotikai, vartojami diabetu - type 2 diabetes mellitusedistride is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exerciseas monotherapy when metformin is considered inappropriate due to intolerance. be kitų vaistų, skirtų gydyti 2 tipo cukrinis diabetas. for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 ir 5. heart failureedistride is indicated in adults for the treatment of symptomatic chronic heart failure. chronic kidney diseaseedistride is indicated in adults for the treatment of chronic kidney disease.
forxiga
astrazeneca ab - dapagliflozino propanedilo monohidratas - diabetes mellitus, type 2; heart failure, systolic; heart failure; renal insufficiency, chronic - narkotikai, vartojami diabetu - type 2 diabetes mellitusforxiga is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exerciseas monotherapy when metformin is considered inappropriate due to intolerance. be kitų vaistų, skirtų gydyti 2 tipo cukrinis diabetas. for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 ir 5. heart failureforxiga is indicated in adults for the treatment of symptomatic chronic heart failure. chronic kidney diseaseforxiga is indicated in adults for the treatment of chronic kidney disease.
pentomycin, injekcinė suspensija
univet ltd. (airija) - injekcinė suspensija - 1 ml suspensijos yra: benzilpenicilino prokaino druskos (atitinka 200 000 tv) - 200 mg, dihidrostreptomicino (sulfato) - 200 mg. - galvijams, avims ir kiaulėms gydyti, sergantiems infekcinėmis ligomis, kurių sukėlėjai jautrūs penicilinui ir dihidrostreptomicinui.